BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36050547)

  • 21. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV.
    Drucker DJ; Shi Q; Crivici A; Sumner-Smith M; Tavares W; Hill M; DeForest L; Cooper S; Brubaker PL
    Nat Biotechnol; 1997 Jul; 15(7):673-7. PubMed ID: 9219272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation strategies to improve the efficacy of intestinal permeation enhancers
    Maher S; Brayden DJ
    Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
    Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of non-covalent self-association on the subcutaneous absorption of a therapeutic peptide.
    Clodfelter DK; Pekar AH; Rebhun DM; Destrampe KA; Havel HA; Myers SR; Brader ML
    Pharm Res; 1998 Feb; 15(2):254-62. PubMed ID: 9523312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
    Shimizu Y; Hara H; Hira T
    Br J Nutr; 2021 Feb; 125(4):398-407. PubMed ID: 32713353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
    Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
    Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acylation of Glucagon-like peptide-2: interaction with lipid membranes and in vitro intestinal permeability.
    Trier S; Linderoth L; Bjerregaard S; Andresen TL; Rahbek UL
    PLoS One; 2014; 9(10):e109939. PubMed ID: 25295731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system.
    Shrestha N; Shahbazi MA; Araújo F; Mäkilä E; Raula J; Kauppinen EI; Salonen J; Sarmento B; Hirvonen J; Santos HA
    Biomaterials; 2015 Nov; 68():9-20. PubMed ID: 26253804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats.
    Qin X; Shen H; Liu M; Yang Q; Zheng S; Sabo M; D'Alessio DA; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G943-9. PubMed ID: 15677555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.
    Mentlein R; Gallwitz B; Schmidt WE
    Eur J Biochem; 1993 Jun; 214(3):829-35. PubMed ID: 8100523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
    Thulesen J
    Curr Protein Pept Sci; 2004 Feb; 5(1):51-65. PubMed ID: 14965320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal Absorption of FITC-Dextrans and Macromolecular Model Drugs in the Rat Intestinal Instillation Model.
    Berg S; Suljovic D; Kärrberg L; Englund M; Bönisch H; Karlberg I; Van Zuydam N; Abrahamsson B; Hugerth AM; Davies N; Bergström CAS
    Mol Pharm; 2022 Jul; 19(7):2564-2572. PubMed ID: 35642793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.
    Drucker DJ
    Curr Pharm Des; 2001 Sep; 7(14):1399-412. PubMed ID: 11472275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The insulinotropic effect of exogenous glucagon-like peptide-1 is not affected by acute vagotomy in anaesthetized pigs.
    Veedfald S; Hansen M; Christensen LW; Larsen SA; Hjøllund KR; Plamboeck A; Hartmann B; Deacon CF; Holst JJ
    Exp Physiol; 2016 Jul; 101(7):895-912. PubMed ID: 27027735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
    Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
    Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon.
    Plaisancie P; Bernard C; Chayvialle JA; Cuber JC
    Endocrinology; 1994 Dec; 135(6):2398-403. PubMed ID: 7988423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length.
    Feltrin KL; Little TJ; Meyer JH; Horowitz M; Smout AJ; Wishart J; Pilichiewicz AN; Rades T; Chapman IM; Feinle-Bisset C
    Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R524-33. PubMed ID: 15166004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.